Chardan NexTech Acquisition Corp.
Status: Pre-IPO
U=S+W
W=S@11.50
| IPO Proceeds, $M | $150.00M |
|---|---|
| IPO Date | * |
| CEO | Jonas Grossman |
| Left Lead | Chardan |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 15+(2*3) |
| IPO Sector |
Technology
Disruptive technology companies that operate within the HealthTech and FinTech sectors |
| IPO Geography | Global |
| Target Company | TBD |
| Deal Announced | TBD |
| Deal Size, $M | TBD |
| Deal Sector | TBD |
| Deal Geography | TBD |
| SEC Filings | www.sec.gov |
| Approval Vote | TBD |
| Amendment Vote | TBD |
CNAQ
CNAQU
CNAQW
Not listed
| Price | |
|---|---|
| Volume, 3-month avg. | N/A |
| Price | |
|---|---|
| Volume, today | |
| Volume, 3-month avg. | N/A |
| Price | |
|---|---|
| Volume, today | |
| Volume, 3-month avg. | N/A |
| Price | |
|---|---|
| Volume, today | |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Chardan NexTech Acquisition Corp.:
- Structure and cap table
- 10 directors & officers
- 3 filings and events
- 2 underwriters
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Kerry Propper | 46 | Co-Founder and Director (Chairman) |
| Jonas Grossman | 46 | Co-Founder, Chief Executive Officer, President, Secretary, Treasurer, and Director |
| Alex Weil | 49 | Chief Operating Officer and Director |
| Gbola Amusa | 47 | Chief Scientific Officer |
| Todd Thomson | 60 | Director |
| Perry Boyle | 57 | Director |
| Noor Sweid | 40 | Director |
| Bryan Mazlish | 48 | Director |
| Colleen DiClaudio | 43 | Director |
| Steven Rosenblatt | 44 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| Chardan | BR | 15,000,000 | units |
| B. Riley FBR | 1 | ||
| 15,000,001 | units | ||
| Up-Front UW fee | 0.33 | % | |
| BCMA | 3.50 | % |
Sign in to view more advisor data.
Filings
Sign in to view 3 filings.